Umezawa K - Search Results

1

Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.

Matsumoto G, Namekawa J, Muta M, Nakamura T, Bando H, Tohyama K, Toi M, Umezawa K. Matsumoto G, et al. Among authors: umezawa k. Clin Cancer Res. 2005 Feb 1;11(3):1287-93. Clin Cancer Res. 2005. PMID: 15709200

2

Antineoplastic effect of erbstatin on human mammary and esophageal tumors in athymic nude mice.

Toi M, Mukaida H, Wada T, Hirabayashi N, Toge T, Hori T, Umezawa K. Toi M, et al. Among authors: umezawa k. Eur J Cancer. 1990;26(6):722-4. doi: 10.1016/0277-5379(90)90126-e. Eur J Cancer. 1990. PMID: 2144161

3

Inhibition of experimental metastasis by an alpha-glucosidase inhibitor, 1,6-epi-cyclophellitol.

Atsumi S, Nosaka C, Ochi Y, Iinuma H, Umezawa K. Atsumi S, et al. Among authors: umezawa k. Cancer Res. 1993 Oct 15;53(20):4896-9. Cancer Res. 1993. PMID: 8402678

4

Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice.

Umezawa K, Taniguchi T, Toi M, Ohse T, Tsutsumi N, Yamamoto T, Koyano T, Ishizuka M. Umezawa K, et al. Drugs Exp Clin Res. 1996;22(2):35-40. Drugs Exp Clin Res. 1996. PMID: 8879977

5

Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells.

Kumeda SI, Deguchi A, Toi M, Omura S, Umezawa K. Kumeda SI, et al. Among authors: umezawa k. Anticancer Res. 1999 Sep-Oct;19(5B):3961-8. Anticancer Res. 1999. PMID: 10628338

6

Synthesis of NF-kappaB activation inhibitors derived from epoxyquinomicin C.

Matsumoto N, Ariga A, To-e S, Nakamura H, Agata N, Hirano S, Inoue J, Umezawa K. Matsumoto N, et al. Among authors: umezawa k. Bioorg Med Chem Lett. 2000 May 1;10(9):865-9. doi: 10.1016/s0960-894x(00)00114-1. Bioorg Med Chem Lett. 2000. PMID: 10853648

7

Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines.

Seki M, Toi M, Kobayashi K, Shitara K, Umezawa K, Seon BK, Kan M, Rhim JS. Seki M, et al. Among authors: umezawa k. Int J Oncol. 2000 Sep;17(3):525-33. doi: 10.3892/ijo.17.3.525. Int J Oncol. 2000. PMID: 10938394

8

Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells.

Ohno O, Shima Y, Ikeda Y, Kondo SI, Kato K, Toi M, Umezawa K. Ohno O, et al. Among authors: umezawa k. Int J Oncol. 2001 May;18(5):1009-15. doi: 10.3892/ijo.18.5.1009. Int J Oncol. 2001. PMID: 11295049

9

Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin.

Ariga A, Namekawa J, Matsumoto N, Inoue J, Umezawa K. Ariga A, et al. Among authors: umezawa k. J Biol Chem. 2002 Jul 5;277(27):24625-30. doi: 10.1074/jbc.M112063200. Epub 2002 Apr 30. J Biol Chem. 2002. PMID: 11983688 Free article.

10

Synthesis and structure-activity relationship of dehydroxymethylepoxyquinomicin analogues as inhibitors of NF-kappaB functions.

Chaicharoenpong C, Kato K, Umezawa K. Chaicharoenpong C, et al. Among authors: umezawa k. Bioorg Med Chem. 2002 Dec;10(12):3933-9. doi: 10.1016/s0968-0896(02)00315-2. Bioorg Med Chem. 2002. PMID: 12413845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

650 results

Search Page

Filters